Variant name,Rx name,#Published
N501Y,CP,148
N501Y,IP,116
N501Y,mAbs phase3,51
N501Y,mAbs structure,17
E484K,CP,90
E484K,IP,57
E484K,mAbs phase3,58
E484K,mAbs structure,17
Other individual mutations,CP,616
Other individual mutations,IP,476
Other individual mutations,mAbs phase3,652
Other individual mutations,mAbs structure,489
All individual mutations,CP,854
All individual mutations,IP,641
All individual mutations,mAbs phase3,752
All individual mutations,mAbs structure,521
B.1.1.7,CP,461
B.1.1.7,IP,444
B.1.1.7,mAbs phase3,66
B.1.1.7,mAbs structure,28
B.1.351,CP,434
B.1.351,IP,277
B.1.351,mAbs phase3,64
B.1.351,mAbs structure,20
P.1,CP,111
P.1,IP,127
P.1,mAbs phase3,28
P.1,mAbs structure,5
B.1.429/B.1.427,CP,32
B.1.429/B.1.427,IP,37
B.1.429/B.1.427,mAbs phase3,3
B.1.429/B.1.427,mAbs structure,0
B.1.526,CP,0
B.1.526,IP,0
B.1.526,mAbs phase3,3
B.1.526,mAbs structure,0
Other combinations of mutations,CP,588
Other combinations of mutations,IP,512
Other combinations of mutations,mAbs phase3,172
Other combinations of mutations,mAbs structure,160
All combinations of mutations,CP,1626
All combinations of mutations,IP,1405
All combinations of mutations,mAbs phase3,345
All combinations of mutations,mAbs structure,215
